SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rocco Barazzoni, Annamaria Semolic, Maria Rosa Cattin, Michela Zanetti, Gianfranco Guarnieri, Acylated ghrelin limits fat accumulation and improves redox state and inflammation markers in the liver of high-fat-fed rats, Obesity, 2014, 22, 1
  2. 2
    T.E. Silva, G. Colombo, L.L. Schiavon, Adiponectin: A multitasking player in the field of liver diseases, Diabetes & Metabolism, 2014, 40, 2, 95

    CrossRef

  3. 3
    Mitchell Guenther, Roland James, Jacqueline Marks, Shi Zhao, Aniko Szabo, Srividya Kidambi, Adiposity distribution influences circulating adiponectin levels, Translational Research, 2014, 164, 4, 270

    CrossRef

  4. 4
    Eric Trépo, Pierre Nahon, Gianluca Bontempi, Luca Valenti, Edmondo Falleti, Hans-Dieter Nischalke, Samia Hamza, Stefano Ginanni Corradini, Maria Antonella Burza, Erwan Guyot, Benedetta Donati, Ulrich Spengler, Patrick Hillon, Pierluigi Toniutto, Jean Henrion, Denis Franchimont, Jacques Devière, Philippe Mathurin, Christophe Moreno, Stefano Romeo, Pierre Deltenre, Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data, Hepatology, 2014, 59, 6
  5. 5
    Koji Sawada, Takaaki Ohtake, Takumu Hasebe, Masami Abe, Hiroki Tanaka, Katsuya Ikuta, Yasuaki Suzuki, Mikihiro Fujiya, Chitomi Hasebe, Yutaka Kohgo, Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice, Hepatology Research, 2014, 44, 8
  6. 6
    Erica Novo, Stefania Cannito, Claudia Paternostro, Claudia Bocca, Antonella Miglietta, Maurizio Parola, Cellular and molecular mechanisms in liver fibrogenesis, Archives of Biochemistry and Biophysics, 2014, 548, 20

    CrossRef

  7. 7
    Shahinul Alam, Utpal Das Gupta, Mahbubul Alam, Jahangir Kabir, Ziaur Rahman Chowdhury, A. K. M. Khorshed Alam, Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh, Indian Journal of Gastroenterology, 2014, 33, 5, 452

    CrossRef

  8. 8
    Anna Maria Lombardi, Roberto Fabris, Giulia Berti de Marinis, Piero Marson, Filippo Navaglia, Mario Plebani, Roberto Vettor, Fabrizio Fabris, Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura, European Journal of Haematology, 2014, 92, 6
  9. 9
    Daniel Shouval, Scott L. Friedman, Focusing on the past, present, and future of hepatology, Journal of Hepatology, 2014, 61, 6, 1196

    CrossRef

  10. 10
    Waseem Hassan, Lin Ding, Rong-Yin Gao, Jun Liu, Jing Shang, Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders, Cytokine, 2014, 66, 2, 133

    CrossRef

  11. 11
    F. Lan, H. Misu, K. Chikamoto, H. Takayama, A. Kikuchi, K. Mohri, N. Takata, H. Hayashi, N. Matsuzawa-Nagata, Y. Takeshita, H. Noda, Y. Matsumoto, T. Ota, T. Nagano, M. Nakagen, K.-i. Miyamoto, K. Takatsuki, T. Seo, K. Iwayama, K. Tokuyama, S. Matsugo, H. Tang, Y. Saito, S. Yamagoe, S. Kaneko, T. Takamura, LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance, Diabetes, 2014, 63, 5, 1649

    CrossRef

  12. 12
    Fabio Marra, Angela Provenzano, Elisa Vivoli, Mechanisms of Fibrosis in Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 142

    CrossRef

  13. 13
    Ester Vanni, Elisabetta Bugianesi, Obesity and Liver Cancer, Clinics in Liver Disease, 2014, 18, 1, 191

    CrossRef

  14. 14
    Raffi Karagozian, Zoltán Derdák, György Baffy, Obesity-associated mechanisms of hepatocarcinogenesis, Metabolism, 2014, 63, 5, 607

    CrossRef

  15. 15
    Yujin Hoshida, Bryan C. Fuchs, Nabeel Bardeesy, Thomas F. Baumert, Raymond T. Chung, Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma, Journal of Hepatology, 2014, 61, 1, S79

    CrossRef

  16. 16
    F. Pacifici, R. Arriga, G. P. Sorice, B. Capuani, M. G. Scioli, D. Pastore, G. Donadel, A. Bellia, S. Caratelli, A. Coppola, F. Ferrelli, M. Federici, G. Sconocchia, M. Tesauro, P. Sbraccia, D. Della-Morte, A. Giaccari, A. Orlandi, D. Lauro, Peroxiredoxin 6, a Novel Player in the Pathogenesis of Diabetes, Diabetes, 2014, 63, 10, 3210

    CrossRef

  17. 17
    Maria Elias-Miró, Mariana Mendes-Braz, Ruben Cereijo, Francesc Villarroya, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho, Sergi Guixé-Muntet, Marta Massip-Salcedo, Joan Carles Domingo, Raquel Bermudo, Juan Rodés, Carmen Peralta, Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion, Journal of Hepatology, 2014, 60, 1, 87

    CrossRef

  18. 18
    Judit Cubedo, Teresa Padró, Juan Cinca, Pedro Mata, Rodrigo Alonso, Lina Badimon, Retinol-binding protein 4 levels and susceptibility to ischaemic events in men, European Journal of Clinical Investigation, 2014, 44, 3
  19. 19
    Kumiko Mera, Hirofumi Uto, Seiichi Mawatari, Akio Ido, Yozo Yoshimine, Tsuyoshi Nosaki, Kohei Oda, Kazuaki Tabu, Kotaro Kumagai, Tsutomu Tamai, Akihiro Moriuchi, Makoto Oketani, Yuko Shimada, Masaaki Hidaka, Susumu Eguchi, Hirohito Tsubouchi, Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C, BMC Gastroenterology, 2014, 14, 1, 27

    CrossRef

  20. 20
    Jasmin Svinka, Wolfgang Mikulits, Robert Eferl, STAT3 in hepatocellular carcinoma: new perspectives, Hepatic Oncology, 2014, 1, 1, 107

    CrossRef

  21. 21
    Vikrant Rachakonda, Charles Gabbert, Amit Raina, Huanan Li, Shahid Malik, James P. DeLany, Jaideep Behari, Stratification of Risk of Death in Severe Acute Alcoholic Hepatitis Using a Panel of Adipokines and Cytokines, Alcoholism: Clinical and Experimental Research, 2014, 38, 11
  22. 22
    Yaxi Chen, Zac Varghese, Xiong Z. Ruan, The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis, Genes & Diseases, 2014, 1, 1, 106

    CrossRef

  23. 23
    Fernando J. Barreyro, Silvia Holod, Paola V. Finocchietto, Alejandra M. Camino, Jorge B. Aquino, Alejandra Avagnina, María C. Carreras, Juan J. Poderoso, Gregory J. Gores, The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis, Liver International, 2014, 34, 10
  24. 24
    Maciej Malinowski, Thomas Konrad, Sabine Nolting, Peter Martus, Diana Hünerbein, Andreas Pfützner, Andreas Pfeiffer, Johan Friso Lock, Antje Schulz, Peter Neuhaus, Martin Stockmann, The role of the liver in the metabolism of adiponectin and proinsulin, Journal of Diabetes Research and Clinical Metabolism, 2014, 3, 1, 4

    CrossRef

  25. 25
    Rabindra Dhital, Oren Tirosh, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  26. 26
    Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro, A 360-degree overview of paediatric NAFLD: Recent insights, Journal of Hepatology, 2013, 58, 6, 1218

    CrossRef

  27. 27
    Bart G.P. Koot, Olga H. van der Baan-Slootweg, Anneloes E. Bohte, Aart J. Nederveen, Jochem R. van Werven, Christine L.J. Tamminga-Smeulders, Maruschka P. Merkus, Frank G. Schaap, Peter L.M. Jansen, Jaap Stoker, Marc A. Benninga, Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children, Obesity, 2013, 21, 3
  28. 28
    Yu Li, Lin Ding, Waseem Hassan, Daoud Abdelkader, Jing Shang, Adipokines and Hepatic Insulin Resistance, Journal of Diabetes Research, 2013, 2013, 1

    CrossRef

  29. 29
    George Ntaios, Nikolaos K. Gatselis, Konstantinos Makaritsis, George N. Dalekos, Adipokines as mediators of endothelial function and atherosclerosis, Atherosclerosis, 2013, 227, 2, 216

    CrossRef

  30. 30
    Toru Arano, Hayato Nakagawa, Hitoshi Ikeda, Kazuhiko Koike, Adiponectin in chronic hepatitis C, Clinical Journal of Gastroenterology, 2013, 6, 4, 259

    CrossRef

  31. 31
    Michał Kukla, Angiogenesis: a phenomenon which aggravates chronic liver disease progression, Hepatology International, 2013, 7, 1, 4

    CrossRef

  32. 32
    Beata Kasztelan-Szczerbinska, Agata Surdacka, Maria Slomka, Jacek Rolinski, Krzysztof Celinski, Agata Smolen, Mariusz Szczerbinski, Association of Serum Adiponectin, Leptin, and Resistin Concentrations with the Severity of Liver Dysfunction and the Disease Complications in Alcoholic Liver Disease, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  33. 33
    Tarek M. Ali, Khalid Al Hadidi, Chemerin is associated with markers of inflammation and predictors of atherosclerosis in Saudi subjects with metabolic syndrome and type 2 diabetes mellitus, Beni-Suef University Journal of Basic and Applied Sciences, 2013, 2, 2, 86

    CrossRef

  34. 34
    Adviti Naik, Rok Košir, Damjana Rozman, Genomic aspects of NAFLD pathogenesis, Genomics, 2013, 102, 2, 84

    CrossRef

  35. 35
    Cristina T.L. Dornelles, Helena A.S. Goldani, Maria Inês A. Wilasco, Rafael L. Maurer, Carlos O. Kieling, Marilene Porowski, Cristina T. Ferreira, Jorge L. Santos, Sandra M.G. Vieira, Themis R. Silveira, Ghrelin, leptin and insulin in cirrhotic children and adolescents: Relationship with cirrhosis severity and nutritional status, Regulatory Peptides, 2013, 180, 26

    CrossRef

  36. 36
    Eric R. Kallwitz, Hepatic fibrosis developing in morbid obesity independent of steatohepatitis: new mechanism or the Rube Goldberg machine?, Hepatology International, 2013, 7, 1, 1

    CrossRef

  37. 37
    Ching-Fen Wu, Yun-Lian Lin, Yi-Tsau Huang, Hepatitis C virus core protein stimulates fibrogenesis in hepatic stellate cells involving the obese receptor, Journal of Cellular Biochemistry, 2013, 114, 3
  38. 38
    T.J. Caperna, A.E. Shannon, W.M. Garrett, T.G. Ramsay, L.A. Blomberg, T.H. Elsasser, Identification and characterization of a nuclear factor-κ B-p65 proteolytic fragment in nuclei of porcine hepatocytes in monolayer culture, Domestic Animal Endocrinology, 2013, 45, 3, 154

    CrossRef

  39. 39
    Hae Yoon Choi, Soon Young Hwang, Chang Hee Lee, Ho Cheol Hong, Sae Jeong Yang, Hye Jin Yoo, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi, Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease, Diabetes & Metabolism Journal, 2013, 37, 1, 63

    CrossRef

  40. 40
    M. Asrih, F. R. Jornayvaz, Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance, Journal of Endocrinology, 2013, 218, 3, R25

    CrossRef

  41. 41
    Lihua Chen, Wenen Liu, Shaojuan Lai, Yanming Li, Xiangxiang Wang, Huibing Zhang, Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients, European Journal of Gastroenterology & Hepatology, 2013, 25, 8, 935

    CrossRef

  42. 42
    Lina Abu-Tair, Sarit Doron, Mahmud Mahamid, Johnny Amer, Rifaat Safadi, Leptin modulates lymphocytes' adherence to hepatic stellate cells is associated with oxidative status alterations, Mitochondrion, 2013, 13, 5, 473

    CrossRef

  43. 43
    D. Goltz, K. Schötta, H. Zhou, H.-P. Fischer, Nichtalkoholische Steatohepatitis mit Zirrhose bei jungen Erwachsenen mit hypothalamisch-hypophysärer Dysfunktion, Der Pathologe, 2013, 34, 4, 318

    CrossRef

  44. 44
    Francisco Barrera, Jacob George, Non-alcoholic fatty liver disease: more than just ectopic fat accumulation, Drug Discovery Today: Disease Mechanisms, 2013, 10, 1-2, e47

    CrossRef

  45. 45
    Carlos Moctezuma-Velázquez, Ignacio García-Juárez, Rodrigo Soto-Solís, Juan Hernández-Cortés, Aldo Torre, Nutritional assessment and treatment of patients with liver cirrhosis, Nutrition, 2013, 29, 11-12, 1279

    CrossRef

  46. 46
    Xiao-Feng Duan, Peng Tang, Qiang Li, Zhen-Tao Yu, Obesity, adipokines and hepatocellular carcinoma, International Journal of Cancer, 2013, 133, 8
  47. 47
    Maciej Gonciarz, Wladyslaw Bielański, Robert Partyka, Tomasz Brzozowski, Piotr C. Konturek, Jerzy Eszyk, Krzysztof Celiński, Russel J. Reiter, Stanislaw J. Konturek, Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin, Journal of Pineal Research, 2013, 54, 2
  48. 48
    Luca Valenti, Paola Dongiovanni, Stefano Ginanni Corradini, Maria Antonella Burza, Stefano Romeo, PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease, Digestive and Liver Disease, 2013, 45, 8, 619

    CrossRef

  49. 49
    Ashraf Elfakhry, Ehab Abdel-Khalek, Sahar El-Gharabawy, Eman El-Tanaihy, Azza Abdelbaky, Predictive value of the adiponectin to leptin ratio for diagnosis of steatohepatitis in patients with nonalcoholic fatty liver disease, Egyptian Liver Journal, 2013, 3, 2, 47

    CrossRef

  50. 50
    Mia Híndi, Cynthia Levy, Claudia A. Couto, Pablo Bejarano, Flavia Mendes, Primary Biliary Cirrhosis is More Severe in Overweight Patients, Journal of Clinical Gastroenterology, 2013, 47, 3, e28

    CrossRef

  51. 51
    Guido Carpino, Anastasia Renzi, Paolo Onori, Eugenio Gaudio, Role of Hepatic Progenitor Cells in Nonalcoholic Fatty Liver Disease Development: Cellular Cross-Talks and Molecular Networks, International Journal of Molecular Sciences, 2013, 14, 10, 20112

    CrossRef

  52. 52
    Chien-Hsieh Chiang, Jin-Shin Lai, Shou-Hung Hung, Long-Teng Lee, Jin-Chuan Sheu, Kuo-Chin Huang, Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers, Obesity, 2013, 21, 2
  53. 53
    Christopher Savard, Erica V. Tartaglione, Rahul Kuver, W. Geoffrey Haigh, Geoffrey C. Farrell, Savitha Subramanian, Alan Chait, Matthew M. Yeh, LeBris S. Quinn, George N. Ioannou, Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis, Hepatology, 2013, 57, 1
  54. 54
    Na Hyun Kim, The Analysis of Non-pharmacological Intervention Study for Nonalcoholic Fatty Liver Disease: Intervention Types and Measurement Parameters, Journal of Korean Biological Nursing Science, 2013, 15, 2, 43

    CrossRef

  55. 55
    E. Fitzpatrick, T. K. Dew, A. Quaglia, R. A. Sherwood, R. R. Mitry, A. Dhawan, Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease, Pediatric Obesity, 2012, 7, 6
  56. 56
    Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman, Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie, Hepatitis Monthly, 2012, 12, 1, 11

    CrossRef

  57. 57
    Sadaf Badar, Bushra Khubaib, Muhammad Idrees, Abrar Hussain, Zunaira Awan, Sadia Butt, Samia Afzal, Madeeha Akram, Zareen Fatima, Mahwish Aftab, Sana Saleem, Sara Munir, Bisma Rauff, Mahrukh Naudhani, Liaquat Ali, Muhammaad Ali, Irshadul Rehman, Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie, Hepatitis Monthly, 2012, 12, 1, 11

    CrossRef

  58. 58
    Mahmoud Aboelneen Khattab, Mohammed Eslam, Mayada M. Aly, Mohammed Shatat, Azaa Hussen, Yossef I. Moussa, Ghada Elsaghir, Hesham Abdalhalim, Ahmed Aly, Salwa Gaber, Stephen A. Harrison, Association of Serum Adipocytokines With Insulin Resistance and Liver Injury in Patients With Chronic Hepatitis C Genotype 4, Journal of Clinical Gastroenterology, 2012, 46, 10, 871

    CrossRef

  59. 59
    Rima Tanabe, Byung-Yoon Cha, Byung Geun Ha, Takayuki Yonezawa, Kazuo Nagai, Je-Tae Woo, Kazumi Yagasaki, DETECTION OF ADIPONECTIN AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 USING A CALIXCROWN DERIVATIVES-COATED PROTEIN CHIP, Journal of Immunoassay and Immunochemistry, 2012, 33, 2, 166

    CrossRef

  60. 60
    Claudia D. Gherman, Aurel I. Mironiuc, Evaluation of Serum Adipokines in Peripheral Arterial Occlusive Disease, Mediators of Inflammation, 2012, 2012, 1

    CrossRef

  61. 61
    Ming-Ling Chang, Huei-Chung Yeh, Yung-Kuan Tsou, Chao-Jan Wang, Hsiao-yang Cheng, Chang-Mu Sung, Yu-Pin Ho, Tsung-Hsing Chen, Chau-Ting Yeh, HCV Core-Induced Nonobese Hepatic Steatosis Is Associated With Hypoadiponectinemia and Is Ameliorated by Adiponectin Administration, Obesity, 2012, 20, 7
  62. 62
    Valerio Nobili, Guido Carpino, Anna Alisi, Antonio Franchitto, Gianfranco Alpini, Rita De Vito, Paolo Onori, Domenico Alvaro, Eugenio Gaudio, Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease, Hepatology, 2012, 56, 6
  63. 63
    György Baffy, Elizabeth M. Brunt, Stephen H. Caldwell, Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace, Journal of Hepatology, 2012, 56, 6, 1384

    CrossRef

  64. 64
    Matheus Truccolo Michalczuk, Camila Rippol Kappel, Oscar Birkhan, Ana Carolina Bragança, Mário Reis Álvares-da-Silva, HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  65. 65
    J. S. Kim, K.-A. Lê, S. Mahurkar, J. N. Davis, M. I. Goran, Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescents, Pediatric Obesity, 2012, 7, 2
  66. 66
    Xiaobing Tan, Xiuhua Sun, Qiong Li, Yantao Zhao, Wei Zhong, Xinguo Sun, Wei Jia, Craig J. McClain, Zhanxiang Zhou, Leptin Deficiency Contributes to the Pathogenesis of Alcoholic Fatty Liver Disease in Mice, The American Journal of Pathology, 2012, 181, 4, 1279

    CrossRef

  67. 67
    Thuy-Anh Le, Rohit Loomba, Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis, Journal of Clinical and Experimental Hepatology, 2012, 2, 2, 156

    CrossRef

  68. 68
    Hayato Nakagawa, Shin Maeda, Molecular Mechanisms of Liver Injury and Hepatocarcinogenesis: Focusing on the Role of Stress-Activated MAPK, Pathology Research International, 2012, 2012, 1

    CrossRef

  69. 69
    Geoffrey C. Farrell, Derrick van Rooyen, Lay Gan, Shivrakumar Chitturi, NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications, Gut and Liver, 2012, 6, 2, 149

    CrossRef

  70. 70
    Ching-Sheng Hsu, Jia-Horng Kao, Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan, Journal of the Formosan Medical Association, 2012, 111, 10, 527

    CrossRef

  71. 71
    Eugenio Gaudio, Valerio Nobili, Antonio Franchitto, Paolo Onori, Guido Carpino, Nonalcoholic fatty liver disease and atherosclerosis, Internal and Emergency Medicine, 2012, 7, S3, 297

    CrossRef

  72. 72
    Lokpal S. Bhatia, Nicholas P. Curzen, Christopher D. Byrne, Nonalcoholic fatty liver disease and vascular risk, Current Opinion in Cardiology, 2012, 27, 4, 420

    CrossRef

  73. 73
    Shani Ben-Shlomo, Francine H. Einstein, Isabel Zvibel, Dikla Atias, Amir Shlomai, Zamir Halpern, Nir Barzilai, Sigal Fishman, Perinephric and Epididymal Fat Affect Hepatic Metabolism in Rats, Obesity, 2012, 20, 1
  74. 74
    Boris Guiu, Elodie Crevisy-Girod, Christine Binquet, Laurence Duvillard, David Masson, Côme Lepage, Samia Hamza, Denis Krausé, Bruno Verges, Anne Minello, Jean-Pierre Cercueil, Patrick Hillon, Jean-Michel Petit, Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy, European Radiology, 2012, 22, 4, 855

    CrossRef

  75. 75
    Michał Kukla, Agnieszka Berdowska, Dominika Stygar, Andrzej Gabriel, Włodzimierz Mazur, Beata Łogiewa-Bazger, Barbara Sobala-Szczygieł, Rafał J Bułdak, Maria Rokitka, Wojciech Zajęcki, Lucjan Kępa, Tomasz Sawczyn, Krystyna Żwirska-Korczala, Serum FGF21 and RBP4 levels in patients with chronic hepatitis C, Scandinavian Journal of Gastroenterology, 2012, 47, 8-9, 1037

    CrossRef

  76. 76
    Chien-Hsieh Chiang, Jin-Shin Lai, Jin-Chuan Sheu, Lee-Lan Yen, Chun-Jen Liu, Kuo-Chin Huang, The risky body mass index ranges for significant hepatitis B viral load: A campus-based study, Obesity Research & Clinical Practice, 2012, 6, 1, e31

    CrossRef

  77. 77
    Joon Sung Kim, The Role of Inflammatory Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease, Pediatric Gastroenterology, Hepatology & Nutrition, 2012, 15, 2, 74

    CrossRef

  78. 78
    Joon Sung Kim, The Role of Inflammatory Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease, Pediatric Gastroenterology, Hepatology & Nutrition, 2012, 15, 2, 74

    CrossRef

  79. 79
    Erdem Akbal, Erdem Koçak, Adnan Taş, Enver Yüksel, Seyfettin Köklü, Visfatin Levels in Nonalcoholic Fatty Liver Disease, Journal of Clinical Laboratory Analysis, 2012, 26, 2
  80. 80
    Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt, MacSween's Pathology of the Liver, 2012,

    CrossRef

  81. 81
    Maurizio Parola, Fabio Marra, Adipokines and Redox Signaling: Impact on Fatty Liver Disease, Antioxidants & Redox Signaling, 2011, 15, 2, 461

    CrossRef

  82. 82
    F. Scaglioni, S. Ciccia, M. Marino, G. Bedogni, S. Bellentani, ASH and NASH, Digestive Diseases, 2011, 29, 2, 202

    CrossRef

  83. 83
    C. Desbois-Mouthon, De la stéatohépatite non alcoolique au carcinome hépatocellulaire : mécanismes physiopathologiques, Médecine des Maladies Métaboliques, 2011, 5, 1, 38

    CrossRef

  84. 84
    W. Kang, M.S. Lee, M. Baik, Dietary Protein Restriction Alters Lipid Metabolism and Insulin Sensitivity in Rats, Asian-Australasian Journal of Animal Sciences, 2011, 24, 9, 1274

    CrossRef

  85. 85
    Karima Begriche, Julie Massart, Marie-Anne Robin, Annie Borgne-Sanchez, Bernard Fromenty, Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver, Journal of Hepatology, 2011, 54, 4, 773

    CrossRef

  86. 86
    Dariela Micheloud, Juan Berenguer, María Guzmán-Fulgencio, Yolanda Campos, Mónica García-Álvarez, Pilar Catalán, Jaime Cosín, Pilar Miralles, Juan Carlos López, Salvador Resino, European Mitochondrial DNA Haplogroups and Metabolic Disorders in HIV/HCV-Coinfected Patients on Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011, 58, 4, 371

    CrossRef

  87. 87
    Ángeles Ruiz-Extremera, Ángel Carazo, Ángela Salmerón, Josefa León, Jorge Casado, Alejandro Goicoechea, José Manuel Fernandez, Maximiliano Garofano, Esther Ocete, Ana Belén Martín, Esther Pavón, Javier Salmerón, Factors Associated With Hepatic Steatosis in Obese Children and Adolescents, Journal of Pediatric Gastroenterology and Nutrition, 2011, 53, 2, 196

    CrossRef

  88. 88
    Ramon Bataller, Krista Rombouts, José Altamirano, Fabio Marra, Fibrosis in alcoholic and nonalcoholic steatohepatitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 231

    CrossRef

  89. 89
    Fabio Marra, Ghrelin and fibrogenesis: Relief for a hungry liver, Journal of Hepatology, 2011, 55, 1, 221

    CrossRef

  90. 90
    Angel Carazo, Josefa León, Jorge Casado, Ana Gila, Sergio Delgado, Ana Martín, Laura Sanjuan, Trinidad Caballero, Jose Antonio Muñoz, Rosa Quiles, Angeles Ruiz-Extremera, Luis Miguel Alcázar, Javier Salmerón, Hepatic Expression of Adiponectin Receptors Increases with Non-alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1, Obesity Surgery, 2011, 21, 4, 492

    CrossRef

  91. 91
    Michael B. Stout, Li-Fen Liu, Martha A. Belury, Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C ε in mice, Molecular Nutrition & Food Research, 2011, 55, 7
  92. 92
    Salvatore Petta, Claudio Tripodo, Stefania Grimaudo, Daniela Cabibi, Calogero Cammà, Antonietta Di Cristina, Vito Di Marco, Gaetano Di Vita, Sabrina Ingrao, Alessandra Mazzola, Giulio Marchesini, Rosaria Pipitone, Antonio Craxì, High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis, Digestive and Liver Disease, 2011, 43, 5, 404

    CrossRef

  93. 93
    Takumi Kawaguchi, Naoto Shiba, Yoshio Takano, Takashi Maeda, Michio Sata, Hybrid training of voluntary and electrical muscle contractions decreased fasting blood glucose and serum interleukin-6 levels in elderly people: a pilot study, Applied Physiology, Nutrition, and Metabolism, 2011, 36, 2, 276

    CrossRef

  94. 94
    Takumi Kawaguchi, Naoto Shiba, Takashi Maeda, Toru Matsugaki, Yoshio Takano, Minoru Itou, Masahiro Sakata, Eitaro Taniguchi, Kensei Nagata, Michio Sata, Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study, Journal of Gastroenterology, 2011, 46, 6, 746

    CrossRef

  95. 95
    I-Cheng Lee, Yi-Hsiang Huang, Che-Chang Chan, Teh-Ia Huo, Chi-Jen Chu, Chiung-Ru Lai, Pui-Ching Lee, Chien-Wei Su, Jaw-Ching Wu, Han-Chieh Lin, Shou-Dong Lee, Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B, Clinical Nutrition, 2011, 30, 5, 647

    CrossRef

  96. 96
    J. Aubert, K. Begriche, L. Knockaert, M.A. Robin, B. Fromenty, Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 10, 630

    CrossRef

  97. 97
    Andrew M. Miller, Hua Wang, Adeline Bertola, Ogyi Park, Norio Horiguchi, Sung Hwan Ki, Shi Yin, Fouad Lafdil, Bin Gao, Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10–deficient mice, Hepatology, 2011, 54, 3
  98. 98
    Mei Mei, Lei Zhao, Qing Li, Yaxi Chen, Ailong Huang, Zac Varghese, John F Moorhead, Suhua Zhang, Stephen H Powis, Qifu Li, Xiong Z Ruan, Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice, Lipids in Health and Disease, 2011, 10, 1, 110

    CrossRef

  99. 99
    Paola Dongiovanni, Anna Ludovica Fracanzani, Silvia Fargion, Luca Valenti, Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target, Journal of Hepatology, 2011, 55, 4, 920

    CrossRef

  100. 100
    Iwan W. Schie, Jian Wu, Tyler Weeks, Mark A. Zern, John C. Rutledge, Thomas Huser, Label-free imaging and analysis of the effects of lipolysis products on primary hepatocytes, Journal of Biophotonics, 2011, 4, 6
  101. 101
    Rodolphe Anty, Maud Lemoine, Liver fibrogenesis and metabolic factors, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, S10

    CrossRef

  102. 102
    Ursula E. Lee, Scott L. Friedman, Mechanisms of hepatic fibrogenesis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 195

    CrossRef

  103. 103
    Michiko Itoh, Takayoshi Suganami, Nobutaka Nakagawa, Miyako Tanaka, Yukio Yamamoto, Yasutomi Kamei, Shuji Terai, Isao Sakaida, Yoshihiro Ogawa, Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis, The American Journal of Pathology, 2011, 179, 5, 2454

    CrossRef

  104. 104
    Jörn M. Schattenberg, Detlef Schuppan, Nonalcoholic steatohepatitis, Current Opinion in Lipidology, 2011, 22, 6, 479

    CrossRef

  105. 105
    Annalisa Berzigotti, Guadalupe Garcia-Tsao, Jaime Bosch, Norman D. Grace, Andrew K. Burroughs, Rosa Morillas, Angels Escorsell, Juan Carlos Garcia-Pagan, David Patch, Daniel S. Matloff, Roberto J. Groszmann, Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis, Hepatology, 2011, 54, 2
  106. 106
    S. Lisi, O. Gamucci, T. Vottari, G. Scabia, M. Funicello, M. Marchi, G. Galli, I. Arisi, R. Brandi, M. D'Onofrio, A. Pinchera, F. Santini, M. Maffei, Obesity-Associated Hepatosteatosis and Impairment of Glucose Homeostasis Are Attenuated by Haptoglobin Deficiency, Diabetes, 2011, 60, 10, 2496

    CrossRef

  107. 107
    Virginia Hernandez-Gea, Scott L. Friedman, Pathogenesis of Liver Fibrosis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 425

    CrossRef

  108. 108
    Massimo Pinzani, Pathophysiology of Non-Alcoholic Steatohepatitis and Basis for Treatment, Digestive Diseases, 2011, 29, 2, 243

    CrossRef

  109. 109
    Pauliina Pisto, Olavi Ukkola, Merja Santaniemi, Y. Antero Kesäniemi, Plasma adiponectin—an independent indicator of liver fat accumulation, Metabolism, 2011, 60, 11, 1515

    CrossRef

  110. 110
    Anna Iacono, Giuseppina Mattace Raso, Roberto Berni Canani, Antonio Calignano, Rosaria Meli, Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms, The Journal of Nutritional Biochemistry, 2011, 22, 8, 699

    CrossRef

  111. 111
    Sittisak Honsawek, Maneerat Chayanupatkul, Voranush Chongsrisawat, Apiradee Theamboonlers, Kesmanee Praianantathavorn, Wanvisa Udomsinprasert, Paisarn Vejchapipat, Yong Poovorawan, Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia, BMC Gastroenterology, 2011, 11, 1, 16

    CrossRef

  112. 112
    Toru Arano, Hayato Nakagawa, Ryosuke Tateishi, Hitoshi Ikeda, Koji Uchino, Kenichiro Enooku, Eriko Goto, Ryota Masuzaki, Yoshinari Asaoka, Yuji Kondo, Tadashi Goto, Shuichiro Shiina, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike, Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients, International Journal of Cancer, 2011, 129, 9
  113. 113
    Bilge Aktas, Yusuf Yilmaz, Fatih Eren, Oya Yonal, Ramazan Kurt, Yesim Ozen Alahdab, Cigdem Ataizi Celikel, Osman Ozdogan, Nese Imeryuz, Cem Kalayci, Erol Avsar, Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease, Metabolism, 2011, 60, 4, 544

    CrossRef

  114. 114
    A. Fisher, E. Southcott, R. Li, W. Srikusalanukul, M. Davis, P. Smith, Serum resistin in older patients with hip fracture: Relationship with comorbidity and biochemical determinants of bone metabolism, Cytokine, 2011, 56, 2, 157

    CrossRef

  115. 115
    Argiro Voumvouraki, Mairi Koulentaki, George Notas, Ourania Sfakianaki, Elias Kouroumalis, Serum surrogate markers of liver fibrosis in primary biliary cirrhosis, European Journal of Internal Medicine, 2011, 22, 1, 77

    CrossRef

  116. 116
    Jee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu, Chia-Yen Dai, Ching-I Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Jeng-Fu Yang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Chern Chen, Wan-Long Chuang, Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection, Journal of Gastroenterology and Hepatology, 2011, 26, 3
  117. 117
    H. Castel, P. Mathurin, Stéatohépatite non alcoolique, EMC - Endocrinologie - Nutrition, 2011, 8, 3, 1

    CrossRef

  118. 118
    Mónica García-Álvarez, Juan Berenguer, Dariela Micheloud, María Guzmán-Fulgencio, Pilar Catalán, Juan Carlos López, Jaime Cosín, Pilar Miralles, Ana Carrero-Gras, Salvador Resino, Sustained Virologic Response Decreases Serum Markers of Angiogenesis, Inflammation, and Fibrosis in HIV/HCV-Coinfected Patients on Hepatitis C Virus Therapy, AIDS Patient Care and STDs, 2011, 110206193127043

    CrossRef

  119. 119
    Jun Xu, Keane K.Y. Lai, Alla Verlinsky, Aurelia Lugea, Samuel W. French, Marcus P. Cooper, Cheng Ji, Hidekazu Tsukamoto, Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK, Journal of Hepatology, 2011, 55, 3, 673

    CrossRef

  120. 120
    Amir J. Guri, Josep Bassaganya-Riera, Systemic Effects of White Adipose Tissue Dysregulation and Obesity-Related Inflammation, Obesity, 2011, 19, 4
  121. 121
    Stergios A. Polyzos, Jannis Kountouras, Christos Zavos, Georgia Deretzi, The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2011, 45, 1, 50

    CrossRef

  122. 122
    Nasreen Z. Ehtesham, Mohammad Nasiruddin, Ayesha Alvi, Battula K. Kumar, Niyaz Ahmed, Sundaresh Peri, Kolluri J.R. Murthy, Seyed E. Hasnain, Treatment end point determinants for pulmonary tuberculosis: Human resistin as a surrogate biomarker, Tuberculosis, 2011, 91, 4, 293

    CrossRef

  123. 123
    Patrick Sauvant, Maud Cansell, Claude Atgié, Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes, Journal of Physiology and Biochemistry, 2011, 67, 3, 487

    CrossRef

  124. 124
    Valerio Nobili, Anna Alisi, Melania Manco, Global Perspectives on Childhood Obesity, 2011,

    CrossRef

  125. 125
    E González-Reimers, F Santolaria-Fernández, Cytokines, 2011,

    CrossRef

  126. 126
    Stergios Polyzos, Jannis Kountouras, Christos Zavos, Adipokines, 2011,

    CrossRef

  127. 127
    Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, 2010, 53, 2, 372

    CrossRef

  128. 128
    C. Duval, U. Thissen, S. Keshtkar, B. Accart, R. Stienstra, M. V. Boekschoten, T. Roskams, S. Kersten, M. Muller, Adipose Tissue Dysfunction Signals Progression of Hepatic Steatosis Towards Nonalcoholic Steatohepatitis in C57Bl/6 Mice, Diabetes, 2010, 59, 12, 3181

    CrossRef

  129. 129
    Heng-cai Yu, Si-ying Li, Ming-feng Cao, Xiu-yun Jiang, Li Feng, Jia-jun Zhao, Ling Gao, Effects of chronic ethanol consumption on levels of adipokines in visceral adipose tissues and sera of rats, Acta Pharmacologica Sinica, 2010, 31, 4, 461

    CrossRef

  130. You have free access to this content130
    Linda K Vaughn, Gerene Denning, Kara L Stuhr, Harriet de Wit, Matthew N Hill, Cecilia J Hillard, Endocannabinoid signalling: has it got rhythm?, British Journal of Pharmacology, 2010, 160, 3
  131. 131
    Scott L. Friedman, Evolving challenges in hepatic fibrosis, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 8, 425

    CrossRef

  132. 132
    Michael Trauner, Marco Arrese, Martin Wagner, Fatty liver and lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010, 1801, 3, 299

    CrossRef

  133. 133
    Ruth M. L. De Bruyne, Emer Fitzpatrick, Anil Dhawan, Fatty liver disease in children: eat now pay later, Hepatology International, 2010, 4, 1, 375

    CrossRef

  134. 134
    J. J. Loor, Genomics of metabolic adaptations in the peripartal cow, animal, 2010, 4, 07, 1110

    CrossRef

  135. 135
    Sylvie Naveau, Anne-Marie Cassard-Doulcier, Micheline Njiké-Nakseu, Laurence Bouchet-Delbos, Nadège Barri-Ova, Hédia Boujedidi, Barbara Dauvois, Axel Balian, Sophie Maitre, Sophie Prévot, Ibrahim Dagher, Hélène Agostini, Liliane Grangeot-Keros, Dominique Emilie, Gabriel Perlemuter, Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease, Journal of Hepatology, 2010, 52, 6, 895

    CrossRef

  136. 136
    Brent A. Neuschwander-Tetri, Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites, Hepatology, 2010, 52, 2
  137. 137
    Elizabeth Hijona, Lander Hijona, Juan I. Arenas, Luis Bujanda, Inflammatory Mediators of Hepatic Steatosis, Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  138. 138
    Gisèle Nkontchou, Jean-Philippe Bastard, Marianne Ziol, Mounir Aout, Emmanuel Cosson, Nathalie Ganne-Carrie, Véronique Grando-Lemaire, Dominique Roulot, Jacqueline Capeau, Jean-Claude Trinchet, Eric Vicaut, Michel Beaugrand, Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis, Journal of Hepatology, 2010, 53, 5, 827

    CrossRef

  139. 139
    Laura Scolaro, Marco Cassone, Jerzy W Kolaczynski, Laszlo Otvos Jr, Eva Surmacz, Leptin-based therapeutics, Expert Review of Endocrinology & Metabolism, 2010, 5, 6, 875

    CrossRef

  140. 140
    Alexis Elias Malavazos, Giulia Gobbo, Roberta Francesca Zelaschi, Emanuele Cereda, Lifestyle intervention and fatty liver disease: The importance of both disrupting inflammation and reducing visceral fat, Hepatology, 2010, 51, 3
  141. 141
    K Widhalm, E Ghods, Nonalcoholic fatty liver disease: a challenge for pediatricians, International Journal of Obesity, 2010, 34, 10, 1451

    CrossRef

  142. 142
    Leon A Adams, Ariel E Feldstein, Nonalcoholic steatohepatitis: risk factors and diagnosis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 5, 623

    CrossRef

  143. 143
    M Arrese, S J Karpen, Nuclear Receptors, Inflammation, and Liver Disease: Insights for Cholestatic and Fatty Liver Diseases, Clinical Pharmacology & Therapeutics, 2010, 87, 4, 473

    CrossRef

  144. 144
    Elizabeth M. Brunt, Pathology of nonalcoholic fatty liver disease, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 4, 195

    CrossRef

  145. 145
    Bao-Ying Chen, Ping Qu, Ru Tie, Miao-Zhang Zhu, Xiao-Xing Zhu, Jun Yu, Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis, Regulatory Peptides, 2010, 164, 2-3, 139

    CrossRef

  146. 146
    Isabel Fernández de Castro, Juan Berenguer, Dariela Micheloud, María Guzmán-Fulgencio, Jaime Cosín, Emilio Álvarez, Juan Carlos López, Pilar Miralles, Mónica García-Álvarez, Salvador Resino, Serum levels of adipokines in HIV/HCV co-infected patients and their association with insulin resistance and liver disease severity, Journal of Infection, 2010, 61, 6, 499

    CrossRef

  147. 147
    Stergios A. Polyzos, Jannis Kountouras, Christos Zavos, Eleni Tsiaousi, The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease, Diabetes, Obesity and Metabolism, 2010, 12, 5
  148. 148
    Lila Missae Oyama, Claudia Maria Oller do Nascimento, June Carnier, Aline de Piano, Lian Tock, Priscila de Lima Sanches, Fabíola Alvise Corrêa Gomes, Sergio Tufik, Marco Túlio de Mello, Ana R. Dâmaso, The role of anorexigenic and orexigenic neuropeptides and peripheral signals on quartiles of weight loss in obese adolescents, Neuropeptides, 2010, 44, 6, 467

    CrossRef

  149. 149
    Jung Sub Lim, Michele Mietus-Snyder, Annie Valente, Jean-Marc Schwarz, Robert H. Lustig, The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 5, 251

    CrossRef

  150. 150
    Stephen A. Harrison, Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?, Hepatology, 2010, 51, 2
  151. 151
    Herbert Tilg, Alexander Moschen, Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation, Current Opinion in Clinical Nutrition and Metabolic Care, 2010, 13, 4, 391

    CrossRef

  152. 152
    Katie Larson Ode, Brigitte I. Frohnert, Brandon M. Nathan, Identification and treatment of metabolic complications in pediatric obesity, Reviews in Endocrine and Metabolic Disorders, 2009, 10, 3, 167

    CrossRef

  153. 153
    Scott L. Friedman, Hepatic Fibrosis,